This page contains a Flash digital edition of a book.

“Pathologically benign meningiomas can recur, even after operations to remove them. “

printed using SurePrint technology. Te flexibility of this technology means that unlimited custom arrays can also be created using the company’s online application eArray.

Te platform, with its set of optimised reagents and hardware, enables highly-sensitive, highly- scalable, and highly-reproducible profiling with low RNA input amounts (down to 10 ng).

Also available are SurePrint G3 Exon Microarrays, with the same level of performance and sensitivity but with comprehensive coverage down to the exon level.

Exon arrays are available for human, mouse, and rat to enable multiple experiments from the same dataset: gene-level, exon-level, and splicing analysis.

lines can be derived in less than 60 days, without amplification; small (4-8kb) DNA elements are capable of making two protein chains per plasmid, for example antibodies; and it integrates with industry standard platforms such as Chinese hamster ovary (CHO) cells, cytomegalovirus (CMV) promoters, plasmids, transfection agents, and media.

Gene expression Another supplier, Agilent, says that it provides the widest selection of gene expression solutions - offering a comprehensive portfolio with the highest array sensitivity, a proven and reliable qPCR platform, an RNA target capture kit and a committed software solution, all with a focus on quality in results.

Te company’s Gene Expression microarray platform, designed for high performance and reliability, provides a flexible and affordable solution for gene expression studies.

Catalogue arrays across 30 species are available for whole-genome studies with 60-mer oligonucleotide probes

After Gene Expression microarray results are obtained, Agilent’s QPCR portfolio enables researchers to verify microarray results or do more detailed analysis on gene expression changes. Its Mx3005P QPCR system provides reliable results in a flexible, easy to use platform – with reagents validated to provide sensitive and reliable quantification down to single-copy detection and two-fold differences in expression.

An additional option in the Gene Expression portfolio is the SureSelect RNA Capture Target Enrichment Kit, enabling the target enrichment of specific transcripts of interest, or as a validation tool for whole transcriptome sequencing experiments..

Easy interface Gene expression results, including microarrays, qPCR, and RNA-Seq, can be studied and summarised using GeneSpring GX and NGS software, which offer high quality analysis with an easy-to-use interface. With over 13,000 citations and an over 12-year track record, Agilent says that GeneSpring is the industry- leading tool for analysis of all its gene expression technologies.

Positioning Systems FOR MICROSCOPY

P-545 – Dynamic Motion in 3 Axes

Travel ranges to 500 µm

Resolution in the nano - meter range

Response time in the range of a few milliseconds

M-687 – Low-Profile, Precision XY Stage

Travel ranges to 135 mm

Minimum incremental motion up to 0.1 µm, highly stable

Velocity to 120 mm/s


– Scans and

Positions Objectives Travel ranges to 1 mm

Resolution in the nano- meter range

Minimum settling time

Positioning systems from PI are particularly suited for the most challenging applications in microscopy, life science, biotechnology or medical technology. They offer subnanometer resolution, large travel ranges and they are extremely fast. For more information, contact us: · Physik Instrumente (PI) GmbH & Co. KG · Tel. +49 (721) 4846-0


For more information ✔ at pi_130380_kombi_m2_89x261_en.indd 1 30.04.13 16:32

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52